Literature DB >> 15126640

Scrapie-like prion protein is translocated to the nuclei of infected cells independently of proteasome inhibition and interacts with chromatin.

Alain Mangé1, Carole Crozet, Sylvain Lehmann, Florence Béranger.   

Abstract

Prion diseases are fatal transmissible neurodegenerative disorders characterized by the accumulation of an abnormally folded isoform of the cellular prion protein (PrP(C)) denoted PrP(Sc). Recently, wild-type and pathogenic PrP mutants have been shown to be degraded by the endoplasmic reticulum-associated degradation proteasome pathway after translocation into the cytosol. We show here that a protease resistant form of PrP accumulated in the nuclei of prion-infected cells independently of proteasome activity, and that this nuclear translocation required an intact microtubule network. Moreover, our results show for the first time that nuclear PrP interacts with chromatin in vivo, which may have physiopathological consequences in prion diseases

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15126640     DOI: 10.1242/jcs.01094

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

1.  Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutations.

Authors:  Carole Crozet; Yea-Lih Lin; Clément Mettling; Chantal Mourton-Gilles; Pierre Corbeau; Sylvain Lehmann; Véronique Perrier
Journal:  J Cell Sci       Date:  2004-10-19       Impact factor: 5.285

2.  Cellular prion protein is present in mitochondria of healthy mice.

Authors:  Robert Faris; Roger A Moore; Anne Ward; Brent Race; David W Dorward; Jason R Hollister; Elizabeth R Fischer; Suzette A Priola
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

3.  Cell-specific metabolism and pathogenesis of transmembrane prion protein.

Authors:  Yaping Gu; Xiu Luo; Subhabrata Basu; Hisashi Fujioka; Neena Singh
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

4.  Biophysical and morphological studies on the dual interaction of non-octarepeat prion protein peptides with copper and nucleic acids.

Authors:  Juliana A P Chaves; Carolina Sanchez-López; Mariana P B Gomes; Tháyna Sisnande; Bruno Macedo; Vanessa End de Oliveira; Carolina A C Braga; Luciana P Rangel; Jerson L Silva; Liliana Quintanar; Yraima Cordeiro
Journal:  J Biol Inorg Chem       Date:  2014-02-21       Impact factor: 3.358

5.  Changes in protein structure and distribution observed at pre-clinical stages of scrapie pathogenesis.

Authors:  Ariane Kretlow; Qi Wang; Michael Beekes; Dieter Naumann; Lisa M Miller
Journal:  Biochim Biophys Acta       Date:  2008-06-14

Review 6.  Interactions of prion protein with intracellular proteins: so many partners and no consequences?

Authors:  Krzysztof Nieznanski
Journal:  Cell Mol Neurobiol       Date:  2009-12-30       Impact factor: 5.046

7.  Nuclear CD24 Drives Tumor Growth and Is Predictive of Poor Patient Prognosis.

Authors:  Jason E Duex; Charles Owens; Ana Chauca-Diaz; Garrett M Dancik; Lauren A Vanderlinden; Debashis Ghosh; Mariah Z Leivo; Donna E Hansel; Dan Theodorescu
Journal:  Cancer Res       Date:  2017-07-03       Impact factor: 12.701

8.  The nucleo-junctional interplay of the cellular prion protein: A new partner in cancer-related signaling pathways?

Authors:  Monique Rousset; Armelle Leturque; Sophie Thenet
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

Review 9.  Cellular aspects of prion replication in vitro.

Authors:  Andrea Grassmann; Hanna Wolf; Julia Hofmann; James Graham; Ina Vorberg
Journal:  Viruses       Date:  2013-01-22       Impact factor: 5.048

10.  Loss of anti-Bax function in Gerstmann-Sträussler-Scheinker syndrome-associated prion protein mutants.

Authors:  Julie Jodoin; Micheal Misiewicz; Priya Makhijani; Paresa N Giannopoulos; Jennifer Hammond; Cynthia G Goodyer; Andréa C LeBlanc
Journal:  PLoS One       Date:  2009-08-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.